Technology News and Research

RSS

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease

Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), to support the development of a novel antibody therapeutic for celiac disease.

11 Mar 2011

GSK announces new NovaMin-containing dental formulation for sensitive teeth

This year, for the first time, millions of Americans will be protecting their sensitive teeth with NovaMin in everyday dental products. Co-inventor Gary Hack, DDS, couldn't be happier.

11 Mar 2011

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

Oxford Nanopore Technologies Ltd today announced an exclusive agreement with Harvard University's Office of Technology Development for the development of graphene for DNA sequencing.

From Oxford Nanopore Technologies 11 Mar 2011

EHSI to sign definitive agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it is moving forward with negotiations toward a profit participation agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

11 Mar 2011

State roundup: Concerns about pay for Mass. health executives, board members

Health insurers Harvard Pilgrim Health Care and Tufts Health Plan said yesterday that their board members will meet later this month to discuss whether to bow to state Attorney General Martha Coakley's wishes and stop taking five-figure annual payments.

11 Mar 2011

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

Caliper Life Sciences, Inc. and HistoRx, Inc., today announced a collaboration to co-develop a new generation of tissue-based imaging and analysis solutions, based on immuno-fluorescence, that will deliver accurate, quantitative, and reproducible measurements of proteins in tissue samples.

11 Mar 2011

CSC implements phase one of NC-MIPS program for healthcare professionals, hospitals

CSC announced today that the company, in conjunction with the State of North Carolina, successfully implemented phase one of the North Carolina Medicaid Incentive Payment System.

11 Mar 2011

Researchers develop web-based approach to solve personal health assessment problem

Health literacy is a prerequisite for well being in the developed world with five out of five ailments being treatable by patients themselves given access to appropriate information.

11 Mar 2011

SAP may serve as effective nanomaterial to prevent prostate cancer spread

When prostate cancer stem cells were enclosed in self-assembling nanomaterials made of peptides, the SAP stopped cancer stem cell colony formation and also stopped the division of cancer cells in laboratory cultures.

11 Mar 2011

Opinions: Cuts to U.S. foreign aid; sustainable agriculture to feed the world; gender gap in agriculture

The U.S.' "influence and strength depend far more on convincing and enabling the peoples of the world to look to us as a partner for prosperity and security," Truman National Security Project Fellow Michael Lieberman writes in a Huffington Post opinion piece reflecting on House Republican's continuing resolution proposal to reduce foreign aid spending.

10 Mar 2011

FDA approves Covidien's LEU-based Mo-99 medical isotope

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has approved the use of molybdenum-99 derived from low-enriched uranium (LEU) in the production of technetium-99m generators.

10 Mar 2011

Positive results from exenatide phase 2 study in patients with type 2 diabetes

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.

10 Mar 2011

FDA grants marketing clearance for Teleflex Arrow NextStep Antegrade Chronic Hemodialysis Catheter

Teleflex Incorporated, a global provider of medical technology products, announced today that its Arrow® NextStep™ Antegrade Chronic Hemodialysis Catheter has received market clearance from the U.S. Food and Drug Administration (FDA). The NextStep Antegrade Chronic Hemodialysis Catheter is designed to attain long-term vascular access for hemodialysis and apheresis.

10 Mar 2011

New book on craniosynostosis

Craniosynostosis - the premature fusion of the cranial sutures of an infant's skull - is a challenging and complex condition that can occur as part of a syndrome or in isolation.

10 Mar 2011

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.

10 Mar 2011

ISCO achieves major milestone in stem cell banking program

International Stem Cell Corporation, announced today the achievement of a major milestone in its efforts to establish a bank of immune-matched parthenogenetic stem cells in the United States by receiving the statutory approvals required to move forward with the next phase of its stem cell banking program.

10 Mar 2011

Diabetes people can benefit from noninvasive polarimetric glucose monitor

People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future get the same results quickly and non-invasively by safely shining a light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and Technology.

10 Mar 2011

Pepscan signs Research and License Agreement with Crucell to devlop novel vaccines

Pepscan Therapeutics, the Dutch biotechnology firm focusing on protein mimicry technology, today announces that it has signed a Research and License Agreement with Crucell Holland B.V. the Dutch developer of vaccines and antibodies.

10 Mar 2011

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

Creabilis SA, a clinical stage European biotechnology company addressing unmet medical needs in dermatology, today announced positive results from its Phase IIa study of its lead product CT327 in psoriasis vulgaris.

10 Mar 2011

BMC anesthesiologist receives Letter of Commendation from WHO for pulse oximetry video

Rafael Ortega, MD, an anesthesiologist at Boston Medical Center and vice-chairman of academic affairs at Boston University School of Medicine, received a Letter of Commendation from the World Health Organization for producing a training video on pulse oximetry.

10 Mar 2011

Technology News and Research

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease

GSK announces new NovaMin-containing dental formulation for sensitive teeth

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

EHSI to sign definitive agreement with OceanBASIS

State roundup: Concerns about pay for Mass. health executives, board members

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

CSC implements phase one of NC-MIPS program for healthcare professionals, hospitals

Researchers develop web-based approach to solve personal health assessment problem

SAP may serve as effective nanomaterial to prevent prostate cancer spread

Opinions: Cuts to U.S. foreign aid; sustainable agriculture to feed the world; gender gap in agriculture

FDA approves Covidien's LEU-based Mo-99 medical isotope

Positive results from exenatide phase 2 study in patients with type 2 diabetes

FDA grants marketing clearance for Teleflex Arrow NextStep Antegrade Chronic Hemodialysis Catheter

New book on craniosynostosis

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

ISCO achieves major milestone in stem cell banking program

Diabetes people can benefit from noninvasive polarimetric glucose monitor

Pepscan signs Research and License Agreement with Crucell to devlop novel vaccines

Positive results from Creabilis CT327 Phase IIa study in patients with psoriasis vulgaris

BMC anesthesiologist receives Letter of Commendation from WHO for pulse oximetry video

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News